Mechanistically, it seems that combined MEK/mTOR inhibition reduces the expressions of Mcl-1 and Bcl-2, two proteins that are known to suppress apoptosis induction in melanoma cells (Lasithiotakis et al, 2008). This evidence concerns the gene MCL1 and melanoma.